Pregabalin Phonophoresis and MET for Knee Osteoarthritis
NCT: NCT07598474 · RECRUITING
Brief Summary
Knee osteoarthritis (OA) is a common condition causing pain, stiffness, and difficulty walking. Many patients with advanced (Grade III) knee OA also experience neuropathic pain - burning, tingling, or electric shock sensations - which is harder to treat with standard physiotherapy. Oral pregabalin works for neuropathic pain but causes side effects like dizziness and drowsiness. This study tests whether delivering pregabalin through the skin using ultrasound (phonophoresis), combined with calf muscle stretching (Muscle Energy Technique), can reduce nerve pain and improve walking better than ultrasound alone.
Frequently Asked Questions
What is Pregabalin Phonophoresis and MET for Knee Osteoarthritis?
Pregabalin Phonophoresis and MET for Knee Osteoarthritis is a clinical trial registered under NCT07598474. Current status: RECRUITING.
What is the status of NCT07598474?
The current status of NCT07598474 (Pregabalin Phonophoresis and MET for Knee Osteoarthritis) is: RECRUITING.
When did Pregabalin Phonophoresis and MET for Knee Osteoarthritis start?
Pregabalin Phonophoresis and MET for Knee Osteoarthritis started on 2026-01-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.